Indefinite Delivery Contract SPE2DX15D9243

The federal contract IDV award SPE2DX15D9243 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,999,999, was awarded by the Defense Logistics Agency (DLA) and is valid through December 31, 2025.

Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers a diverse array of prescription drugs, over-the-counter medications, biologics, and medical consumables, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. The IDC is further supported by specific delivery orders, such as SPE2DX23FGX24 and SPE2DX22FGF86, which provide firm fixed-price orders for pharmaceutical items to the DLA.